New developments in antibody therapy for acute myeloid leukemia

Keyphrases

• Acute Myeloid Leukemia 100%
• Antibody Therapy 100%
• Monoclonal Antibody 33%
• Chemotherapy 33%
• High Risk 33%
• Targeted Therapy 33%
• Lymphoma 33%
• Improved Survival 33%
• Older Individuals 33%
• Antibody Conjugates 33%
• Hematopoietic Stem Cell Transplant 33%
• Relapsed Disease 33%
• Chronic Myeloid Leukemia 33%
• CD33 33%
• Age at Diagnosis 33%
• Myelodysplasia 33%
• Mylotarg 33%
• Gemtuzumab Ozogamicin 33%
• Calicheamicin 33%
• Leukemic Blast 33%
• Survival Impact 33%

Medicine and Dentistry

• Acute Myeloid Leukemia 100%
• Antibody Therapy 100%
• Diseases 66%
• Gemtuzumab Ozogamicin 66%
• Chemotherapy 33%
• Hematopoietic Stem Cell Transplantation 33%
• Myelodysplastic Syndrome 33%
• Chronic Myelogenous Leukemia 33%
• Calicheamicin 33%
• CD33 Antigen 33%
• Targeted Therapy 33%
• Monoclonal Antibody 33%